Welcome to the IoT Slam® Internet of Things Conference - The world's most trusted IoT event brand
|

Applications and Considerations for GenAI in Healthcare

Applications and Considerations for GenAI in Healthcare

Session Abstract:

The panel on “Applications and Considerations for GenAI in Healthcare” explores the transformative potential of generative AI in the healthcare sector. The discussion will delve into diverse applications, ranging from drivers of adoption to workforce enablement. Experts will address the ethical and regulatory considerations surrounding the integration of GenAI, examining issues such as data privacy and responsible use of AI in medical decision-making. Attendees can expect a lively exploration of how GenAI stands poised to revolutionize healthcare delivery while navigating the complex landscape of ethical and regulatory challenges.

Speakers:

Catherine (CJ) Robison, BSN, RN, is a Health Innovation Scientist at Oracle Health – Propelled by the belief that data, research and innovative solutions have the power to transform healthcare, CJ Robison has developed a diverse and extensive portfolio of expertise in the medical field. As a registered nurse with a degree in biology, CJ began her career on a medical-surgical floor that specializes in geriatric oncology. Following her time in direct patient care, she served as the Magnet Program Director and Manager of Professional Practice at Sentara Leigh Hospital in Virginia where she was instrumental in improving electronic workflows, running workload-acuity models and quantifying resources required to deliver care.  Following this effort, CJ went on to design and manage an array of process improvement initiatives across Sentara.  During the early days of the Pandemic, CJ led a region-wide COVID-mask-making initiative, managing over 1,000 volunteers. In three months, over 40,000 masks  were delivered to nearly 100 organizations throughout the Hampton Roads region. In her “free” time, CJ enjoys spending time with her three rambunctious children, reading extensively and riding horses.

Karen Finger is Global Lead, Connected Health Strategy and Innovation for Verizon’s Global Enterprise Healthcare and Life Sciences solutions ecosystem. Karen brings over 25+ years of Industry, IT and Communications technology leadership working with many of the largest companies in the world, leading teams, spearheading digital transformation, building trusted strategic partnerships and pioneering industry leading platforms that deliver improved outcomes. Prior to Verizon, she was an early entrant in the Telehealth and Telemedicine industry where she had the opportunity to lead the commercialization strategies for both non-profit and for-profit start-up and early-stage telehealth and telemedicine companies focused on the transformation of care delivery. In her current role, Karen is dedicated to leveraging cutting-edge technologies to build secure, connected health platforms that revolutionize patient care, accelerate operational efficiencies and enable clinical innovation in the ever-evolving landscape of healthcare. Karen is a passionate advocate for shaping the future of healthcare by creating opportunities for collaboration with Providers, Payers, Retail Health, and Medtech Partners that democratize and extend access to care, improve the patient and provider experience, reduce costs, expand growth and deliver improved quality and health outcomes. Karen holds a degree in Computer Science and Business Administration from the University of Florida. Outside of work, Karen has been an active volunteer and Industry leader having served on the board of Emerge Scholarships devoted to economic empowerment for women, as well as served as President of the Association of Telecommunications Professionals, and currently sits on the Executive Advisory Board for the Atlanta Technology Professionals dedicated to connecting, learning and giving back. She enjoys Orange Theory workouts (when they are over), Pickleball, fostering rescue dogs and spending time with her two, adult children.

Romina Elias is a part of the Dell Healthcare Life Sciences team serving as a Chief Nursing Informatics Officer with over 17 years of healthcare experience. A nurse by trade, Romina’s passion for patient care and healthcare IT motivates her to help deliver technologies that would positively impact both clinicians and patients alike. Prior to joining Dell, Romina was a Nursing Executive where she drove quality outcomes and patient experience results by developing efficient processes in healthcare delivery. Her team received the prestigious Beacon Gold award for clinical excellence as well as the Guardian of Excellence Award for outstanding patient experience 3 years in a row. Romina has led a diverse team of nurses and physicians through two successful Joint Commission surveys, DOH visits and most recently, the COVID pandemic. Utilizing limited resources and managing dynamic healthcare needs, she leveraged years of operational leadership experience to implement processes to safely care for patients throughout the pandemic. Romina utilized her experience in health informatics to lead organizations through electronic medical record upgrades and implementations. In the spring of 2021, she served as the Nursing lead for the Epic EMR implementation, ensuring patient safety and clinician satisfaction while maintaining and improving key performance indicators. Romina also has a passion for learning. She has a Master of Science in Nursing Informatics from Walden University and a Doctorate in Nursing Practice from Capella University. She holds both a Nursing Informatics and a Nurse Executive – Advance certificate from the American Credentialing Center. Romina is an advocate of furthering the nursing profession through education and has mentored several nurses through their pursuit of advanced degrees.

Carolyn Walsh, Chief Commercial Officer, BioIntelliSense, In this role, Carolyn is responsible for the marketing and commercial performance, revenue achievement, channel development and sustained growth of the BioIntelliSense business. BioIntelliSense is a continuous health monitoring and clinical intelligence company in the rapid growth phase of its medical grade Data-as-a-Service (DaaS) platform, FDA-cleared BioButton® wearable medical device, FDA-cleared AlertWatch® clinical intelligence solution and advanced analytics for scalable continuous patient monitoring from in-hospital to home. Prior to joining BioIntelliSense, Carolyn Walsh served as the Vice President and Head of Sales and Business Development for the Fitbit Health Solutions group providing leading wearable devices, along with enterprise grade software and services, to inspire and deliver continuous health improvement.
Prior to joining Fitbit Health Solutions, Walsh served as Senior Director of Global Marketing for Qualcomm Life, Inc. Ms. Walsh joined the Qualcomm Life leadership team from HealthyCircles, an enterprise healthcare software-as-a-service platform company, where she led Business Development and Client Services. HealthyCircles was acquired by Qualcomm Life in April 2013.
Prior to HealthyCircles, Walsh served as the Global Director of New Ventures, Franchise Development for Johnson & Johnson Diabetes Care. Walsh was responsible for the digital health strategy, software innovations and formulating growth strategies for emerging markets of India and China. While at Johnson & Johnson, Walsh served in global commercial leadership roles spanning acute, health care professional and consumer engagement channels.
Before transitioning into the health care industry, Walsh was a versatile executive with Coca-Cola with a proven track record of success in sales management, strategic marketing, brand building and channel development in a major U.S. market along with international assignments in Poland and New Zealand.
Walsh holds a Bachelor’s of Science degree from Northern Illinois University and MBA from Loyola University of Chicago.
Recognized as Top 50 Women Leaders in Wellness and Fitness in 2023

 

Register Now: